Literature DB >> 24260605

Polymorphisms in the promoters of MMP-2 and TIMP-2 genes in patients with acne vulgaris.

Kursat Oguz Yaykasli1, Hakan Turan, Ertugrul Kaya, Omer Faruk Hatipoglu.   

Abstract

Acne, a chronic inflammatory skin disease, can be seen at any age but it most often occurs in adolescents and young people. Several factors, including increased sebum production, abnormal cornification of the pilosebaceous units, proliferation of Propionibacterium acne, and extracellular matrix (ECM) remodeling, are thought to be associated with the pathogenesis of the acne. The remodeling of the ECM is regulated by a balance between matrix metalloproteinases (MMPs) and their inhibitors called tissue inhibitors of metalloproteinases (TIMPs). The current study investigated the potential association between MMP-2 (-1306 C/T) and TIMP-2 (-418 G/C) polymorphisms and the risk for acne in a Turkish population. The study was conducted with 85 subjects who presented to the Dermatology Department of Duzce University Hospital. DNA was isolated from 2 ml of peripheral blood taken from each subject, and their genotypes were analyzed with the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The CC, CT, and TT genotypes for MMP-2 (-1306 C/T) polymorphism were similar between the patient and control group (24 [55.8%], 17 [39.5%], and 2 [4.7%], respectively, vs. 21 [50%], 18 [42.9%], and 3 [7.1%], respectively). However, the distribution of the GG, GC, and CC genotypes for TIMP-2 (-418 G/C) polymorphism were different between the patient and control group (30 [69.8%], 9 [14.8%] and 4 [9.3%], respectively, vs. 26 [61.9%], 14 [33.3%], and 2 [4.8%], respectively). The results demonstrated that the TIMP-2 (-418 CC) genotype was nearly two times more common in the patient group compared to the control group (p=0.686, OR=1.45). It may be possible that the TIMP-2 (-418 CC) genotype increases the tendency to develop acne vulgaris by disrupting the balance between MMPs and TIMPs. Further investigations are needed to clarify more precisely the relationship between acne and MMP-TIMP genes.

Entities:  

Keywords:  Acne vulgaris; MMPs; TIMPs; polymorphism

Year:  2013        PMID: 24260605      PMCID: PMC3832336     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  30 in total

Review 1.  New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Authors:  Diane Thiboutot; Harald Gollnick; Vincenzo Bettoli; Brigitte Dréno; Sewon Kang; James J Leyden; Alan R Shalita; Vicente Torres Lozada; Diane Berson; Andrew Finlay; Chee Leok Goh; María Isabel Herane; Ana Kaminsky; Raj Kubba; Alison Layton; Yoshiki Miyachi; Montserrat Perez; Jaime Piquero Martin; Marcia Ramos-E-Silva; Jo Ann See; Neil Shear; John Wolf
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

Review 2.  New and emerging treatments in dermatology: acne.

Authors:  A Katsambas; C Dessinioti
Journal:  Dermatol Ther       Date:  2008 Mar-Apr       Impact factor: 2.851

Review 3.  Acne vulgaris.

Authors:  Hywel C Williams; Robert P Dellavalle; Sarah Garner
Journal:  Lancet       Date:  2011-08-29       Impact factor: 79.321

Review 4.  Epidemiology of acne vulgaris.

Authors:  K Bhate; H C Williams
Journal:  Br J Dermatol       Date:  2013-03       Impact factor: 9.302

5.  Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.

Authors:  Priyanka Srivastava; Tasleem A Lone; Rakesh Kapoor; Rama Devi Mittal
Journal:  Arch Med Res       Date:  2012-02-26       Impact factor: 2.235

6.  The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.

Authors:  Pornchai O-Charoenrat; Patchariya Khantapura
Journal:  Oral Oncol       Date:  2005-11-04       Impact factor: 5.337

7.  Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.

Authors:  Sewon Kang; Soyun Cho; Jin Ho Chung; Craig Hammerberg; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

8.  Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.

Authors:  Kürşat Oğuz Yaykaşli; Muhammet Ali Kayikçi; Nesibe Yamak; Hatice Soğuktaş; Selma Düzenli; Ali Osman Arslan; Ahmet Metın; Ertuğrul Kaya; Ömer Faruk Hatıpoğlu
Journal:  Turk J Med Sci       Date:  2014       Impact factor: 0.973

9.  Interleukin-1A +4845(G> T) polymorphism is a factor predisposing to acne vulgaris.

Authors:  K Szabó; G Tax; K Kis; K Szegedi; D G Teodorescu-Brinzeu; C Diószegi; A Koreck; M Széll; L Kemény
Journal:  Tissue Antigens       Date:  2010-08-19

10.  A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial.

Authors:  Robyn N Smith; Neil J Mann; Anna Braue; Henna Mäkeläinen; George A Varigos
Journal:  Am J Clin Nutr       Date:  2007-07       Impact factor: 7.045

View more
  3 in total

Review 1.  Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris.

Authors:  Anwar Al-Hammadi; Abla Al-Ismaily; Sameer Al-Ali; Rajesh Ramadurai; Rishi Jain; Lynn McKinley-Grant; Tariq I Mughal
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

2.  Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis.

Authors:  Anna Hwee Sing Heng; Yee-How Say; Yang Yie Sio; Yu Ting Ng; Fook Tim Chew
Journal:  BMC Med Genomics       Date:  2021-04-13       Impact factor: 3.063

3.  NF-ĸβ upregulates ADAMTS5 expression by direct binding after TNF-α treatment in OUMS-27 chondrosarcoma cell line.

Authors:  Dilek Gun Bilgic; Omer Faruk Hatipoglu; Sadık Cigdem; Abdulkadir Bilgic; Tulin Cora
Journal:  Mol Biol Rep       Date:  2020-05-15       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.